Tizanidine Hcl Tablet
Product Images NDC 80425-0024

7 FDA label images from Advanced Rx Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hcl (NDC 80425-0024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

Fig 1
A line graph showing plasma concentration (ng/mL) of 4 mg Tizanidine over time (hours) from dosing. It compares four conditions: 4 mg tablets and capsules, each with and without food. Concentrations peak between 1 and 2 hours then decline to near zero by 10 hours post-dose.*
FDA Label Image

Fig 2

Fig 2
A line graph showing improvement in Ashworth Score over 6 hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The graph illustrates changes in Ashworth Score on the y-axis and time in hours on the x-axis, with error bars for variability.*
FDA Label Image

Fig 3

Fig 3
A line plot depicting improvement in Ashworth Score over study periods comparing tizanidine (mean dose 28.8 mg) and placebo groups. The x-axis shows study time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The y-axis represents improvement, ranging from -6 to 2, with tizanidine showing greater improvement than placebo at all points.*
FDA Label Image

Structure

Structure
Chemical structure diagram of Tizanidine HCL, showing the molecular arrangement including rings and functional groups with chlorine and nitrogen atoms depicted.*
FDA Label Image

Tizanidine HCl 4mg Tab Qty 30 Ndc 80425 0024

Tizanidine HCl 4mg Tab Qty 30 Ndc 80425 0024
Label for Tizanidine HCL 4 mg tablets by Advanced Rx of Tennessee, LLC, with NDC 80425-0024-03. The label includes the manufacturer's location in Nashville, TN, and storage instructions to keep at room temperature 20° - 25°C (68° - 77°F). The lot number, expiration date, and a caution about federal law restricting transfer are also visible.*
FDA Label Image

Tizanidine HCl 4mg Tab Qty 60 Ndc 80425 0024

Tizanidine HCl 4mg Tab Qty 60 Ndc 80425 0024
Tizanidine HCL 4 mg tablet packaging label from Advanced Rx of Tennessee, LLC, Nashville, TN. The label includes proprietary and generic names, dosage strength, bottle count (#60), NDC number 80425-0024-01, lot number, expiration date, and storage instructions (20°-25°C). It also features a barcode and a federal warning about drug transfer.*
FDA Label Image

Tizanidine HCl 4mg Tab Qty 90 Ndc 80425 0024

Tizanidine HCl 4mg Tab Qty 90 Ndc 80425 0024
Label for Tizanidine HCL 4 mg tablets, package of 90, by Advanced Rx of Tennessee, LLC. The label includes a comparison to Zanaflex, the product NDC 80425-0024-02, lot number 90TIZ4322, and an expiration date of 3/31/2022. Storage instructions specify room temperature 20°-25°C (68°-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.